Regeneration of nigrostriatal dopaminergic axons by degradation of chondroitin sulfate is accompanied by elimination of the fibrotic scar and glia limitans in the lesion site

Journal of Neuroscience Research

Volumn 85, Issue 3, 2007, Pages 536-547

  Li, Hong Peng ^a,b   Homma, Akiko ^a   Sango, Kazunori ^a   Kawamura, Koki ^a   Raisman, Geoffrey ^c   Kawano, Hitoshi ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Brain injury; Chondroitin sulfate proteoglycans; Chondroitinase ABC; Fibrotic scar; Regeneration

Indexed keywords

CHONDROITIN ABC LYASE; CHONDROITIN SULFATE; COLLAGEN TYPE 4; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FIBROSIS; GLIA CELL; IMMUNOREACTIVITY; MALE; MOUSE; NERVE FIBER REGENERATION; NERVE INJURY; NERVE LESION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; SCAR FORMATION; UPREGULATION;

ANIMALS; AXONS; BRAIN INJURIES; CHONDROITIN ABC LYASE; CHONDROITIN SULFATES; CICATRIX; CORPUS STRIATUM; DOPAMINE; MALE; MICE; MICE, INBRED ICR; MODELS, ANIMAL; NERVE REGENERATION; NEUROGLIA; SUBSTANTIA NIGRA;

EID: 33847281868     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21141     Document Type: Article

References (61)

1. Ahmed Z, Dent RG, Leadbeater WE, Smith C, Berry M, Logan A. 2005. Matrix metalloproteases: degradation of the inhibitory environment of the transected optic nerve and the scar by regenerating axons. Mol Cell Neurosci 28:64-78.
2. Asher RA, Morgenstern DA, Shearer MC, Adcock KH, Pesheva P, Fawcett JW. 2002. Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J Neurosci 22:2225-2236.
3. Berry M, Maxwell WL, Logan A, Mathewson A, McConnell P, Ashhurst DE, Thomas GH. 1983. Deposition of scar tissue in the central nervous system. Acta Neurochir Suppl 32:31-53.
4. Bodo M, Pezzetti F, Giammarioli M, Bellucci C, Baroni T, Becchetti E. 1994. Chondroitin sulphates and embryonic chick skin fibroblast proliferation. Eur J Histochem 38:253-260.
5. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW, McMahon SB. 2002. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416:636-640.
6. Bruckner G, Bringmann A, Hartig W, Koppe G, Delpech B, Brauer K. 1998. Acute and long-lasting changes in extracellular-matrix chondroitin-sulphate proteoglycans induced by injection of chondroitinase ABC in the adult rat brain. Exp Brain Res 121:300-310.
7. Bundesen LQ, Scheel TA, Bregman BS, Kromer LF. 2003. Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. J Neurosci 23:7789-7800.
8. Carulli D, Laabs T, Geller HM, Fawcett JW. 2005. Chondroitin sulfate proteoglycans in neural development and regeneration. Curr Opin Neurobiol 15:116-120.
9. Chung KY, Taylor JS, Shum DK, Chan SO. 2000. Axon routing at the optic chiasm after enzymatic removal of chondroitin sulfate in mouse embryos. Development 127:2673-2683.
10. Davies SJ, Fitch MT, Memberg SP, Hall AK, Raisman G, Silver J. 1997. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390:680-683.
11. Davies SJ, Goucher DR, Doller C, Silver J. 1999. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 19:5810-5822.
12. de Castro R Jr, Tajrishi R, Claros J, Stallcup WB. 2005. Differential responses of spinal axons to transection: influence of the NG2 proteoglycan. Exp Neurol 192:299-309.
13. Dou CL, Levine JM. 1994. Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan. J Neurosci 14:7616-7628.
14. Fidler PS, Schuette K, Asher RA, Dobbertin A, Thornton SR, Calle-Patino Y, Muir E, Levine JM, Geller HM, Rogers JH, Faissner A, Fawcett JW. 1999. Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2. J Neurosci 19:8778-8788.
15. Fouad K, Schnell L, Bunge MB, Schwab ME, Liebscher T, Pearse DD. 2005. Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci 25:1169-1178.
16. Friedlander DR, Milev P, Karthikeyan L, Margolis RK, Margolis RU, Grumet M. 1994. The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J Cell Biol 125:669-680.
17. Haas CA, Rauch U, Thon N, Merten T, Deller T. 1999. Entorhinal cortex lesion in adult rats induces the expression of the neuronal chondroitin sulfate proteoglycan neurocan in reactive astrocytes. J Neurosci 19:9953-9963.
18. Hamel MG, Mayer J, Gottschall PE. 2005. Altered production and proteolytic processing of brevican by transforming growth factor beta in cultured astrocytes. J Neurochem 93:1533-1541.
19. Hermanns S, Klapka N, Muller HW. 2001. The collagenous lesion scar - an obstacle for axonal regeneration in brain and spinal cord injury. Restor Neurol Neurosci 19:139-148.
20. Höke A, Silver J. 1996. Proteoglycans and other repulsive molecules in glial boundaries during development and regeneration of the nervous system. Prog Brain Res 108:149-163.
21. Houle JD, Tom VJ, Mayes D, Wagoner G, Phillips N, Silver J. 2006. Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J Neurosci 26:7405-7415.
22. Ikegami T, Nakamura M, Yamane J, Katoh H, Okada S, Iwanami A, Watanabe K, Ishii K, Kato F, Fujita H, Takahashi T, Okano HJ, Toyama Y, Okano H. 2005. Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury. Eur J Neurosci 22:3036-3046.
23. Iseda T, Nishio T, Kawaguchi S, Kawasaki T, Wakisaka S. 2003. Spontaneous regeneration of the corticospinal tract after transection in young rats: collagen type IV deposition and astrocytic scar in the lesion site are not the cause but the effect of failure of regeneration. J Comp Neurol 464:343-355.
24. Jones LL, Yamaguchi Y, Stallcup WB, Tuszynski MH. 2002. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci 22:2792-2803.
25. Jones LL, Sajed D, Tuszynski MH. 2003. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition. J Neurosci 23:9276-9288.
26. Kawano H, Li HP, Sango K, Kawamura K, Raisman G. 2005. Inhibition of collagen synthesis overrides the age-related failure of regeneration of nigrostriatal dopaminergic axons. J Neurosci Res 80:191-202.
27. Krekoski CA, Neubauer D, Zuo J, Muir D. 2001. Axonal regeneration into acellular nerve grafts is enhanced by degradation of chondroitin sulfate proteoglycan. J Neurosci 21:6206-6213.
28. Li Y, Field PM, Raisman G. 1997. Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science 277:2000-2002.
29. Li Y, Field PM, Raisman G. 1998. Regeneration of adult rat corticospinal axons induced by transplanted olfactory ensheathing cells. J Neurosci 18:10514-10524.
30. Li Y, Carlstedt T, Berthold CH, Raisman G. 2004. Interaction of transplanted olfactory-ensheathing cells and host astrocytic processes provides a bridge for axons to regenerate across the dorsal root entry zone. Exp Neurol 188:300-308.
31. Li Y, Li D, Raisman G. 2005. Interaction of olfactory ensheathing cells with astrocytes may be the key to repair of tract injuries in the spinal cord: the "pathway hypothesis." J Neurocytol 34:343-351.
32. Logan A, Frautschy SA, Gonzalez AM, Sporn MB, Baird A. 1992. Enhanced expression of transforming growth factor beta 1 in the rat brain after a localized cerebral injury. Brain Res 587:216-225.
33. Logan A, Berry M, Gonzalez AM, Frautschy SA, Sporn MB, Baird A. 1994. Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat. Eur J Neurosci 6:355-363.
34. Loy DN, Crawford CH, Darnall JB, Burke DA, Onifer SM, Whittemore SR. 2002. Temporal progression of angiogenesis and basal lamina deposition after contusive spinal cord injury in the adult rat. J Comp Neurol 445:308-324.
35. Lu J, Feron F, Mackay-Sim A, Waite PM. 2002. Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. Brain 125:14-21.
36. Mathewson AJ, Berry M. 1985. Observations on the astrocyte response to a cerebral stab wound in adult rats. Brain Res 327:61-69.
37. Matsui F, Oohira A. 2004. Proteoglycans and injury of the central nervous system. Congenit Anom 44:181-188.
38. Maxwell WL, Follows R, Ashhurst DE, Berry M. 1990. The response of the cerebral hemisphere of the rat to injury. I. The mature rat. Philos Trans R Soc Lond B Biol Sci 328:479-500.
39. McKeon RJ, Hoke A, Silver J. 1995. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp Neurol 136:32-43.
40. McKeon RJ, Jurynec MJ, Buck CR. 1999. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J Neurosci 19:10778-10788.
41. Milev P, Friedlander DR, Sakurai T, Karthikeyan L, Flad M, Margolis RK, Grumet M, Margolis RU. 1994. Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules. J Cell Biol 127:1703-1715.
42. Moon LD, Asher RA, Rhodes KE, Fawcett JW. 2001. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat Neurosci 4:465-466.
43. Moon LD, Asher RA, Rhodes KE, Fawcett JW. 2002. Relationship between sprouting axons, proteoglycans and glial cells following unilateral nigrostriatal axotomy in the adult rat. Neuroscience 109:101-117.
44. Morgenstern DA, Asher RA, Fawcett JW. 2002. Chondroitin sulphate proteoglycans in the CNS injury response. Prog Brain Res 137:313-332.
45. O'Brien MF, Lenke LG, Lou J, Bridwell KH, Joyce ME. 1994. Astrocyte response and transforming growth factor-beta localization in acute spinal cord injury. Spine 19:2321-2329; discussion 2330.
46. Pasterkamp RJ, Giger RJ, Ruitenberg MJ, Holtmaat AJ, De Wit J, De Winter F, Verhaagen J. 1999. Expression of the gene encoding the chemorepellent semaphorin III is induced in the fibroblast component of neural scar tissue formed following injuries of adult but not neonatal CNS. Mol Cell Neurosci 13:143-166.
47. Properzi F, Carulli D, Asher RA, Muir E, Camargo LM, van Kuppevelt TH, ten Dam GB, Furukawa Y, Mikami T, Sugahara K, Toida T, Geller HM, Fawcett JW. 2005. Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia. Eur J Neurosci 21:378-390.
48. Sandyk R. 1999. Serotonergic neuronal sprouting as a potential mechanism of recovery in multiple sclerosis. Int J Neurosci 97:131-138.
49. Schmalfeldt M, Bandtlow CE, Dours-Zimmermann MT, Winterhalter KH, Zimmermann DR. 2000. Brain derived versican V2 is a potent inhibitor of axonal growth. J Cell Sci 113:807-816.
50. Schnadelbach O, Mandl C, Faissner A. 1998. Expression of DSD-1-PG in primary neural and glial-derived cell line cultures, upregulation by TGF-beta, and implications for cell-substrate interactions of the glial cell line Oli-neu. Glia 23:99-119.
51. Shearer MC, Fawcett JW. 2001. The astrocyte/meningeal cell interface - a barrier to successful nerve regeneration? Cell Tissue Res 305:267-273.
52. Silver J, Miller JH. 2004. Regeneration beyond the glial scar. Nat Rev Neurosci 5:146-156.
53. Smith GM, Strunz C. 2005. Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes. Glia 52:209-218.
54. Snyder SE, Li J, Schauwecker PE, McNeill TH, Salton SR. 1996. Comparison of RPTP zeta/beta, phosphacan, and trkB mRNA expression in the developing and adult rat nervous system and induction of RPTP zeta/beta and phosphacan mRNA following brain injury. Brain Res Mol Brain Res 40:79-96.
55. Syrokou A, Tzanakakis G, Tsegenidis T, Hjerpe A, Karamanos NK. 1999. Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure-function relationship. Cell Prolif 32:85-99.
56. Tan AM, Zhang W, Levine JM. 2005. NG2: a component of the glial scar that inhibits axon growth. J Anat 207:717-725.
57. Thon N, Haas CA, Rauch U, Merten T, Fassler R, Frotscher M, Deller T. 2000. The chondroitin sulphate proteoglycan brevican is upregulated by astrocytes after entorhinal cortex lesions in adult rats. Eur J Neurosci 12:2547-2558.
58. Yamada H, Fredette B, Shitara K, Hagihara K, Miura R, Ranscht B, Stallcup WB, Yamaguchi Y. 1997. The brain chondroitin sulfate proteoglycan brevican associates with astrocytes ensheathing cerebellar glomeruli and inhibits neunte outgrowth from granule neurons. J Neurosci 17:7784-7795.
59. Yang LJ, Lorenzini I, Vajn K, Mountney A, Schramm LP, Schnaar RL. 2006. Sialidase enhances spinal axon outgrowth in vivo. Proc Natl Acad Sci U S A 103:11057-11062.
60. Yick LW, Wu W, So KF, Yip HK, Shum DK. 2000. Chondroitinase ABC promotes axonal regeneration of Clarke's neurons after spinal cord injury. Neuroreport 11:1063-1067.
61. Zuo J, Neubauer D, Dyess K, Ferguson TA, Muir D. 1998. Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue. Exp Neurol 154:654-662.